Effect of Doxazosin With and Without Rho-Kinase Inhibitor on Human Corpus Cavernosum Smooth Muscle in the Presence of Bladder Outlet Obstruction

Journal of Urology

Volumn 175, Issue 6, 2006, Pages 2345-2349

  Demir, Omer ^a   Murat, Nergis ^a   Aslan, Guven ^a   Gidener, Sedef ^a   Esen, Ahmet Adil ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

doxazosin; impotence; penis; prostatic hyperplasia; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; PHENYLEPHRINE; RHO KINASE INHIBITOR;

ADRENERGIC ACTIVITY; ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; ERECTILE DYSFUNCTION; HUMAN; HUMAN TISSUE; IC 50; IMPLANTATION; MALE; PENIS PROSTHESIS; PRIORITY JOURNAL; SMOOTH MUSCLE; STATISTICAL SIGNIFICANCE;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXAZOSIN; HUMANS; IMPOTENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE RELAXANTS, CENTRAL; MUSCLE, SMOOTH; PENIS; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; URINARY BLADDER NECK OBSTRUCTION;

EID: 33646367872     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(06)00281-3     Document Type: Article

References (20)

1. Saenz de Tejada I., Kim N., Lagan I., Krane R.J., and Goldstein I. Modulations of adrenergic activity in penile corpus cavernosum. J Urol 142 (1989) 1117
2. Somlyo A.P., and Somlyo A.V. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522 (2000) 177
3. Rees R.W., Ralph D.J., Royle M., Moncada S., and Cellek S. Y-27632, an inhibitor of rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br J Pharmacol 133 (2001) 455
4. Chitaley K., Wingard C.J., Clinton Webb R., Branam H., Stopper V.S., Lewis R.W., et al. Antagonism of rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 7 (2001) 119
5. Chang S., Hypolite J.A., Zderic S.A., Wein A.J., Chacko S., and Disanto M.E. Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via rho-kinase. Am J Physiol Regul Integr Comp Physiol 289 (2005) R1124
6. Chang S., Hypolite J.A., Zderic S.A., Wein A.J., Chacko S., and DiSanto M.E. Enhanced force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. J Urol 167 (2002) 2636
7. Puente J.G. Relationship between age, lower urinary tract symptoms (LUTS) and various domains of erectile dysfunction (ED) in 1098 patients with BPH in the PREDICT study. J Urol 159 (1998) 331
8. Venkateswarlu K., Giraldi A., Zhao W., Wang H.Z., Melman A., Spektor M., et al. Potassium channels and human corporeal smooth muscle cell tone. diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers. J Urol 168 (2002) 355
9. Rosen R.C., Giuliano F., and Carson C.C. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol 47 (2005) 824
10. Minneman K.P., Theroux T.L., Hollinger S., Han C., and Esbenshade T.A. Selectivity of agonists for cloned a1-adrenergic receptor subtypes. Mol. Pharmacol 46 (1994) 929
11. Taniguchi N., Ukai Y., Tanaka T., Yano J., Kimura K., Moriyama N., et al. Identification of alpha 1-adrenoceptor subtypes in the human prostatic urethra. Naunyn Schmiedebergs Arch Pharmacol 355 (1997) 412
12. Kirby R.S., O'Leary M.P., and Carson C. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction. BJU Int 95 (2005) 103
13. Goldstein I. Oral phentolamine. an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. Int J Impot Res 12 suppl. (2000) S75
14. De Rose A.F., Giglio M., Traverso P., Lantieri P., and Carmignani G. Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy. Int J Impot Res 14 (2002) 50
15. De Rose A.F., Carmignani G., Corbu C., Gigilio M., and Traverso P. Observational multicentric trial performed with doxazosin. evaluation of sexual effects on patients with diagnosed benign prostatic hyperplasia. Urol Int 68 (2002) 95
16. Seo K.K., Lee M.Y., Lim S.W., and Kim S.C. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin. J Korean Med Sci 14 (1999) 69
17. Chang S., Hypolite J.A., Changolkar A., Wein A.J., Chacko S., and DiSanto M.E. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via rho-kinase beta. Int J Impot Res 15 (2003) 53
18. Bing W., Chang S., Hypolite J.A., DiSanto M.E., Zderic S.A., Rolf L., et al. Obstruction-induced changes in urinary bladder smooth muscle contractility. a role for rho kinase. Am J Physiol Renal Physiol 285 (2003) F990
19. Rees R.W., Foxwell N.A., Ralph D.J., Kell P.D., Moncada S., and Cellek S. Y-27632, a rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells. J Urol 170 (2003) 2517
20. von Haehling S., Anker S.D., and Bassenge E. Statins and the role of nitric oxide in chronic heart failure. Heart Fail Rev 8 (2003) 99